A Retrospective Study on Inotuzumab Ozogamicin in Infants and Young Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

被引：1

作者：

Brivio, Erica ^{[1
,2
]}

Hoogendijk, Raoull ^{[1
]}

Chantrain, Christophe ^{[3
]}

Rialland, Fanny ^{[4
]}

Contet, Audrey ^{[5
]}

Elitzur, Sarah ^{[6
]}

Dalla-Pozza, Luciano ^{[7
]}

Kallay, Krisztian ^{[8
]}

Li, Chi Kong ^{[9
]}

Kato, Motohiro ^{[10
]}

Markova, Inna V. ^{[11
]}

Schmiegelow, Kjeld ^{[12
]}

Bodmer, Nicole ^{[13
]}

Pieters, Rob ^{[1
]}

Zwaan, Christian Michel ^{[1
,2
]}

机构：

[1] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[2] Erasmus MC, Dept Pediat Oncol Hematol, Sophia Childrens Hosp, Rotterdam, Netherlands

[3] CHC Liege, Clin Esperance, Div Pediat Hematol Oncol, Montegnee, Belgium

[4] CHU Nantes, Nantes, France

[5] CHRU Nancy, Childrens Hosp, Dept Hematol & Oncol, Vandoeuvre Les Nancy, France

[6] Schneider Childrens Med Ctr Israel, Pediat Hematol Oncol, Petah Tiqwa, Israel

[7] Childrens Hosp Westmead, Canc Ctr Children, Westmead, NSW, Australia

[8] Cent Hosp Southern Pest, Pediat Hematol & Stem Cell Transplantat Dept, Natl Inst Hematol & Infect Dis, Budapest, Hungary

[9] Chinese Univ Hong Kong, Dept Paediat, Prince Wales Hosp, Hong Kong, Peoples R China

[10] Natl Ctr Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan

[11] First Pavlov State Med Univ St Petersburg, Raisa Gorbacheva Mem Sci Inst Children Oncol Hema, St Petersburg, Russia

[12] Rigshosp Univ Hosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark

[13] Univ Childrens Hosp Zurich, Zurich, Switzerland

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-126472

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3890

引用

页数：4

共 50 条

[41] Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (vol 33, pg 884, 2018) [J].

Bhojwani, Deepa ;

Sposto, Richard ;

Shah, Nirali N. ;

Rodriguez, Vilmarie ;

Yuan, Constance ;

Stetler-Stevenson, Maryalice ;

O'Brien, Maureen M. ;

McNeer, Jennifer L. ;

Quereshi, Amrana ;

Cabannes, Aurelie ;

Schlegel, Paul ;

Rossig, Claudia ;

Dalla-Pozza, Luciano ;

August, Keith ;

Alexander, Sarah ;

Bourquin, Jean-Pierre ;

Zwaan, Michel ;

Raetz, Elizabeth A. ;

Loh, Mignon L. ;

Rheingold, Susan R. .

LEUKEMIA, 2019, 33 (04) :1061-1062

[42] Outcome of Relapsed or Refractory Acute B-Lymphoblastic Leukemia Patients with Extramedullary Disease Receiving Inotuzumab Ozogamicin [J].

Kayser, Sabine ;

Sartor, Chiara ;

Panitz, Nydia ;

Fante, Matthias ;

Lutz, Christoph ;

Wolff, Daniel ;

Ho, Anthony ;

Papayannidis, Cristina .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S265-S265

[43] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia [J].

Savoy, J. Michael ;

Welch, Mary Alma ;

Nasnas, Patrice E. ;

Kantarjian, Hagop ;

Jabbour, Elias .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (12) :347-356

[44] Weekly Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory CD22-Positive Acute Lymphoblastic Leukemia [J].

DeAngelo, Daniel ;

Stock, Wendy ;

Petersdorf, Stephen ;

Wang, Shaw-Ling ;

Volkert, Angela ;

Vandendries, Erik ;

Advani, Anjali .

BLOOD, 2012, 120 (21)

[45] Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia [J].

Marks, David, I ;

Kebriaei, Partow ;

Stelljes, Matthias ;

Goekbuget, Nicola ;

Kantarjian, Hagop ;

Advani, Anjali S. ;

Merchant, Akil ;

Stock, Wendy ;

Cassaday, Ryan D. ;

Wang, Tao ;

Zhang, Hui ;

Loberiza, Fausto ;

Vandendries, Erik ;

DeAngelo, Daniel J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) :1720-1729

[46] Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review [J].

Marks, David I. ;

Cassaday, Ryan D. ;

Ribera, Josep-Maria ;

Schuh, Andre C. ;

Park, Jae H. ;

Chiaretti, Sabina ;

Stelljes, Matthias .

EXPERT REVIEW OF HEMATOLOGY, 2025, 18 (01) :91-103

[47] Inotuzumab Ozogamicin for Patients with relapsed or refractory acute Lymphoblastic Leukemia: Effective Option also in Patients with extramedullary Disease [J].

不详 .

ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (03) :142-142

[48] Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study [J].

DeAngelo, Daniel J. ;

Stock, Wendy ;

Stein, Anthony S. ;

Shustov, Andrei ;

Liedtke, Michaela ;

Schiffer, Charles A. ;

Vandendries, Erik ;

Liau, Katherine ;

Ananthakrishnan, Revathi ;

Boni, Joseph ;

Laird, A. Douglas ;

Fostvedt, Luke ;

Kantarjian, Hagop M. ;

Advani, Anjali S. .

BLOOD ADVANCES, 2017, 1 (15) :1167-1180

[49] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia [J].

Zaina T. Al-Salama .

Targeted Oncology, 2018, 13 :525-532

[50] Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia [J].

Al-Salama, Zaina T. .

TARGETED ONCOLOGY, 2018, 13 (04) :525-532

← 1 2 3 4 5 →